Bank of America’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $72.9M | Sell |
|
|||||
|
2025
Q2 | $70.5M | Buy |
|
|||||
|
2025
Q1 | $47.2M | Buy |
|
|||||
|
2024
Q4 | $47.7M | Buy |
|
|||||
|
2024
Q3 | $50.8M | Buy |
|
|||||
|
2024
Q2 | $50.9M | Buy |
|
|||||
|
2024
Q1 | $58.8M | Buy |
|
|||||
|
2023
Q4 | $43.3M | Buy |
|
|||||
|
2023
Q3 | $30.9M | Sell |
|
|||||
|
2023
Q2 | $42.4M | Buy |
|
|||||
|
2023
Q1 | $23.4M | Buy |
|
|||||
|
2022
Q4 | $17.3M | Sell |
|
|||||
|
2022
Q3 | $96.1M | Buy |
|
|||||
|
2022
Q2 | $74.5M | Buy |
|
|||||
|
2022
Q1 | $45.6M | Buy |
|
|||||
|
2021
Q4 | $35.3M | Sell |
|
|||||
|
2021
Q3 | $94M | Buy |
|
|||||
|
2021
Q2 | $94.4M | Buy |
|
|||||
|
2021
Q1 | $45.3M | Buy |
|
|||||
|
2020
Q4 | $45.5M | Buy |
|
|||||
|
2020
Q3 | $5.92M | Sell |
|
|||||
|
2020
Q2 | $5.75M | Buy |
|
|||||
|
2020
Q1 | $2.66M | Buy |
|
|||||
|
2019
Q4 | $2.88M | Sell |
|
|||||
|
2019
Q3 | $3.18M | Buy |
|
|||||
|
2019
Q2 | $786K | Sell |
|
|||||
|
2019
Q1 | $1.26M | Buy |
|
|||||
|
2018
Q4 | $164K | Sell |
|
|||||
|
2018
Q3 | $351K | Sell |
|
|||||
|
2018
Q2 | $553K | Buy |
|
|||||
|
2018
Q1 | $340K | Sell |
|
|||||
|
2017
Q4 | $235K | Sell |
|
|||||
|
2017
Q3 | $223K | Hold |
|
|||||
|
2017
Q2 | $199K | Sell |
|
|||||
|
2017
Q1 | $316K | Sell |
|
|||||
|
2016
Q4 | $436K | Buy |
|